Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Laura Lorenzetti
Stay informed with Laura Lorenzetti’s coverage and analysis for Coins2Day.
Page 73 of 73
Kindred offers $533 million to buy Atlanta healthcare rival
By
Senior Editor
SpoonRocket reels in top chef, and $11 million
By
Trading Desk
PeopleDoc secures $17.5 million in funding
By
News Correspondent
The Whistle scores funding, celebrity approval
By
Editorial Team
Yahoo buys ‘self-destruct’ mobile messaging app Blink
By
Senior Editor
Google shatters the Glass ceiling
By
News Correspondent
As mortgage rates fall slightly, borrowers look to refinance
By
News Correspondent
Fannie and Freddie overseer won’t slice loan limits
By
Trading Desk
Valeant ready to beef up bid for maker of Botox
By
Senior Editor
Pfizer admits to potential job losses in AstraZeneca takeover
By
News Correspondent
BSkyB looking to buy into Italian and German pay-TV markets
By
Staff Writer
AIG homes in on two homegrown execs for new CEO
By
Digital Assets Editor
Finance
Pfizer prepares to woo U.K. lawmakers in bid for rival AstraZeneca
By
Blockchain Reporter
Finance
Hilton sees a rosy year ahead as earnings surge
By
Staff Writer
AstraZeneca shares climb in hopes of bigger Pfizer offer
By
Staff Writer